Previous studies indicate that FSH (Follicle Stimulating Hormone), unlike LH (Luteinizing Hormone), promotes the growth and development of cancer cells and limits the process of cancer cell apoptosis in ovarian cancer. Here, BRD2 is linked to cancer.